Myomo (MYO) Enterprise Value Growth (1y) (2017 - 2025)
Myomo (MYO) Enterprise Value Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Myomo | 43.01 Mn | 24.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.85% |
| Sep 30, 2025 | -84.76% |
| Jun 30, 2025 | -76.54% |
| Mar 31, 2025 | -123.29% |
| Dec 31, 2024 | -184.69% |
| Sep 30, 2024 | 37.07% |
| Jun 30, 2024 | -0.28% |
| Mar 31, 2024 | -18.30% |
| Dec 31, 2023 | -65.84% |
| Sep 30, 2023 | -50.28% |
| Jun 30, 2023 | 12.50% |
| Mar 31, 2023 | 28.43% |
| Dec 31, 2022 | 65.56% |
| Sep 30, 2022 | 41.30% |
| Jun 30, 2022 | 25.68% |
| Mar 31, 2022 | 25.49% |
| Dec 31, 2021 | -26.82% |
| Sep 30, 2021 | 5.34% |
| Jun 30, 2021 | -28.31% |
| Mar 31, 2021 | -26.55% |